- Topics, Trends & Updates for May (5/5/22)
- New Guidance: Adopting a Patient-Centered Approach to Sexual Health (4/28/22)
- New Guidance: Questions, Answers, and Best Practices for Expedited Partner Therapy (EPT) (4/19/22)
- Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (4/7/22)
- Updated: Screening for Cervical Dysplasia and Cancer in Adults With HIV (3/29/22)
- Updated: Mycoplasma genitalium Management in Adults (3/28/22)
- Updated: Screening for Anal Dysplasia and Cancer in Adults With HIV (2/22/22)
- FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years (5/17/22)
- FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV (5/16/22)
- HIVinfo Releases New HIV and COVID-19 Fact Sheet (5/12/22)
- FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals (5/5/22)
- FDA Approves First COVID-19 Treatment for Young Children (4/25/22)
- FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples (4/14/22)
- NYCDOHMH: CDC Allows Second COVID-19 Boosters for Certain People (3/31/22)
- NYS Medicaid Update – Special Edition (5/18/22)
- HIVinfo: Updated Resources Available: FDA-Approved HIV Medicines (5/16/22)
- AETC NCRC: May 2022 Monthly Update (5/12/22)
- CEI Newsletter (5/10/22)
- NYSDOH: Hepatitis C (HCV) Dashboard Launches (5/2/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (4/12/22)
- HIVinfo: Updated HHS Pediatric Antiretroviral Therapy Guidelines Released (4/12/22)
The New York State Department of Health (NYSDOH) AIDS Institute (AI) Clinical Guidelines Program is a longstanding, collaborative effort of the AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases.
The program produces and publishes evidence-based, state-of-the-art clinical practice guidelines that establish uniform standards of care for NYS to improve the health and well-being of all adults who receive prevention services or treatment for HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders.
Learn more: